NCT00382460View on ClinicalTrials.gov

Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)

PHASE4CompletedINTERVENTIONAL
Enrollment

4,000

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Actue Coronary Syndromes
Interventions
DRUG

PRAVASTATIN SODIUM

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY